News
2015
-
-
Sysmex Becomes the First in Japan1 to Realize Automated Detection of Lymph Node Metastasis of Non-Small-Cell Lung Cancer
- Application of the OSNA® Method Expanded to Include Non-Small-Cell Lung Cancer, Following Application for Breast Cancer, Colorectal Cancer and Stomach Cancer -
-
-
Blood-based RAS biomarker test now available in Germany
-
-
Sysmex Establishes New Subsidiary in Ghana
- Reinforcing the Company’s Business Foundation in the Markets of West and Central Africa -
-
-
Sysmex Opens Lab within the National Cancer Center to Promote the Development of New Cancer Diagnosis Methods
-
-
Sysmex Wins 20th “IR Grand Prix Award” from Japan Investor Relations Association
-
-
Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2016 (PDF:717KB)
-
-
Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2015, and Revision of Full-Year Financial Results Forecasts (PDF:110KB)
-
-
Announcement Regarding Dividends from Surplus (Commemorative Dividend) (PDF:101KB)
-
-
Sysmex Selected by the Securities Analysts Association of Japan for Excellence in Corporate Disclosure and Excellence in Disclosure to Individual Investors
-
-
Sysmex Wins Awards in 2015 Kinki Local Commendation for Inventions
-
-
Sysmex Extends Funding for Kobe University Graduate School of Medicine Course
-
-
Sysmex Selected for Inclusion in the Asia Pacific Index of the Dow Jones Sustainability Indexes for Fourth Consecutive Year
-
-
Sysmex to Open New R&D Open Innovation Lab
-
-
Sysmex to Expand U.S. Reagent Factory
- Aiming to Meet Growing Demand in the Americas -
-
-
Sysmex Launches its Next-Generation Models in the Sediment Urinalysis Testing Field, the UF-5000/4000/3000 Fully Automated Analyzers of Formed Elements in Urine
-
-
Sysmex Receives in Vitro Diagnostic Approval for Manufacturing and Sales of Three Platelet Aggregation Agonist Reagent Kits
- Pursuing Efficiency and Standardization by Automating Platelet Aggregation Tests -
-
-
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2016 (PDF:681KB)
-
-
Sysmex Completes Expansion of Reagent Factory in Germany
- Increasing Reagent Production Capacity by 50% to Meet Growing Demand in EMEA -
-
-
Sysmex to Participate in the Global Health Innovative Technology Fund
-
-
Sysmex and LabCorp Announce a Strategic Collaboration for Blood-Based Molecular Testing Services and Products to Support the Development of Precision Medicine in Oncology
-
-
RIKEN GENESIS Co., Ltd., Becomes Japan's First Registered CLIA Lab
-
-
Sysmex Accredited ISO 15195 Laboratory medicine - Requirements for reference measurement laboratories
- Initiatives toward Further Standardization of Clinical Testing and Quality Improvement -
-
-
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2015 (PDF:601KB)
-
-
Sysmex Announces Changes from Financial Results Forecasts, Year-End Dividend for the Fiscal Year Ended March 31, 2015, and Dividend Policy (PDF:106KB)
-
-
Sysmex Announces New Group Mid-Term Management Plan
- Preparing the Company to Move to the Next Stage by Reinforcing Growth and Profitability, Investing in Growth and Promoting Transformation - (PDF:178KB)
-
-
Sysmex to Participate in "Global Human Resource Development Community" Japan Public-Private Partnership Student Study Abroad Program
-
-
Sysmex Signs Agreement with Cambodia's Ministry of Health Related to Scientific Support Activities Aimed at Enhancing the Quality of Clinical Testing
-
-
Medicaroid Corporation Commences Full-Fledged Development of Medical Robots
-
-
Insurance Coverage for Sysmex's Reagent to Monitor Therapeutic Gains on Chronic Myelogenous Leukemia (CML) (ipsogen BCR-ABL1 Mbcr IS-MMR DX Kit)
-
-
Sysmex to Establish the Global Communication Center as a Place to Facilitate Unfettered Communication and Prompt Ideas
-
-
Sysmex to Be Special Sponsor of the Kobe Marathon 2015
- We are pleased to have sponsored this exciting event since its inception in 2011 -
-
-
FY2014 Nakatani Award and Research Grant Recipients Announced (PDF:96KB)
-
-
Sysmex Invests in iPS PORTAL, Inc., Aiming to Contribute to Regenerative Medicine
-
-
Announcement of Organizational and Personnel Changes (PDF:231KB)
-
-
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2015 (PDF:808KB)
-
-
Sysmex Launches the CS-1600 Automated Blood Coagulation Analyzer, a New Compact Model in the Hemostasis field
-
-
Hepatic fibrosis test reagent (HISCL M2BPGi Assay Kit) receives approval for health insurance coverage
- Speedy blood sample-based test for measuring the progression of hepatic fibrosis from chronic hepatitis to cirrhosis of the liver -